"Rifamycins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of ANTI-BACTERIAL AGENTS characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known ANTI-BACTERIAL AGENTS. They have been isolated from fermentation broths of Streptomyces mediterranei.
| Descriptor ID |
D012294
|
| MeSH Number(s) |
D03.633.400.811 D04.345.295.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Rifamycins".
Below are MeSH descriptors whose meaning is more specific than "Rifamycins".
This graph shows the total number of publications written about "Rifamycins" by people in this website by year, and whether "Rifamycins" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Rifamycins" by people in Profiles.
-
Felicilda-Reynaldo RF. Ammonia abolishers: antibiotics for hepatic encephalopathy. Medsurg Nurs. 2012 May-Jun; 21(3):173-5; quiz 176.
-
Maclayton DO, Eaton-Maxwell A. Rifaximin for treatment of hepatic encephalopathy. Ann Pharmacother. 2009 Jan; 43(1):77-84.